C

China Dasheng Biotechnology Co
OTC:CDBT

Watchlist Manager
China Dasheng Biotechnology Co
OTC:CDBT
Watchlist
Price: 0.0424 USD 37.22%
Market Cap: $1.7m

Dividends

China Dasheng Biotechnology Co
does not pay dividends

Shareholder Yield

Current shareholder yield for CDBT is hidden .

Shareholder Yield
LOCKED
Unlock
What is shareholder yield?
Dividend Yield
No dividends
Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

CDBT Price
China Dasheng Biotechnology Co

Annual Price Range
0.0424
52w Low
0.0245
52w High
0.15
Price Metrics
Average Annual Return 224.07%
Standard Deviation of Annual Returns 498.96%
Max Drawdown -100%
Shares Statistics
Market Capitalization 1.7m USD
Shares Outstanding 40 980 000
Percentage of Shares Shorted
N/A

CDBT Return Decomposition
Main factors of price return

Stock Splits

No Stock Splits Found

We don't have any information about CDBT's stock splits.

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett